1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc XNAS: BEAM
21.17 0.01 (0.05%)
2.0M
XNAS Volume

XNAS 14 Jul, 2025 5:30 PM (EDT)

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 17 analysts

Beam Therapeutics Inc has a share price target of US$ 44, revenue growth forecast of -12.8%, and profit growth estimate of -12.3% for FY25, based on top 17 analyst calls.